Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases

Yigan Zhang, Yumei Lei,Yanbin Dong, Shuwen Chen, Siyuan Sun, Fange Zhou,Zhiwen Zhao,Bonan Chen,Lv Wei,Juan Chen,Zhongji Meng

PHARMACOLOGY & THERAPEUTICS(2024)

引用 0|浏览2
暂无评分
摘要
RNA ac4C modification is a novel and rare chemical modification observed in mRNA. Traditional biochemical studies had primarily associated ac4C modification with tRNA and rRNA until in 2018, Arango D et al. first re-ported the presence of ac4C modification on mRNA and demonstrated its critical role in mRNA stability and trans-lation regulation. Furthermore, they established that the ac4C modification on mRNA is mediated by the classical N-acetyltransferase NAT10. Subsequent studies have underscored the essential implications of NAT10 and mRNA ac4C modification across both physiological and pathological regulatory processes. In this review, we aimed to explore the discovery history of RNA ac4C modification, its detection methods, and its regulatory mechanisms in disease and physiological development. We offer a forward-looking examination and discourse concerning the employment of RNA ac4C modification as a prospective therapeutic strategy across diverse diseases. Further-more, we comprehensively summarize the functions and mechanisms of NAT10 in gene expression regulation and pathogenesis independent of RNA ac4C modification.(c) 2023 Elsevier Inc. All rights reserved.
更多
查看译文
关键词
NAT10,mRNA ac4C,RNA modification,Tumor,Drug development,Epitranscriptomic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要